Clinical trial
Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose…
NCT00261339 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00261339 |
|---|---|
| Title | Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506) |
| Official title | PRISM: Determination of the Performance Characteristics of ReQuest (TradeMark) in Practice in the Stepped Down Management of GORD |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Gastroesophageal Reflux, GERD, GORD |
| Intervention type | Drug |
| Interventions | Pantoprazole |
| Enrollment | 300 |
| Start date | Aug 1, 2005 |
| First posted | Dec 5, 2005 |
| Last update posted | May 7, 2012 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: